Nifty Pharma Share Price
Open at
26,008.05
52W High
26,135.75
52W Low
21,149.90
Last Updated on 17 Jul 2026, 12:00 am
As on 17th July 2026, the Nifty Pharma is trading at ₹25,645.00, down by 1.40% from the previous close. The index opened at ₹26,008.05, and over the past 52 weeks, it has moved between a low of ₹21,149.90 and a high of ₹26,135.75.
| Date | Close |
|---|---|
| 22 Jun | 24,762.9 |
| 23 Jun | 24,989.95 |
| 24 Jun | 25,018.95 |
| 25 Jun | 24,969.5 |
| 29 Jun | 25,227.9 |
| 30 Jun | 25,326.4 |
| 01 Jul | 25,182.7 |
| 02 Jul | 25,308.9 |
| 03 Jul | 25,745.15 |
| 06 Jul | 25,866.25 |
| 07 Jul | 25,677.7 |
| 08 Jul | 25,429.8 |
| 09 Jul | 25,656.25 |
| 10 Jul | 25,674.1 |
| 13 Jul | 25,643.35 |
| 14 Jul | 25,907.1 |
| 15 Jul | 26,003.6 |
| 16 Jul | 26,008.05 |
| 17 Jul | 25,645 |
Nifty Pharma Performance Today
Nifty Pharma Historical Performance
Nifty Pharma Stocks List
Last Updated: 17 Jul 2026, 12:00 am
| Company | LTP (Rs) | Weight % | M.Cap (Cr) | 52W High | 52W Low |
|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd | 1,932.60 | 23.11% | 463,695.48 | 1,962.70 | 1,548.00 |
Divis Laboratories Ltd | 7,247.50 | 9.59% | 192,398.35 | 7,390.00 | 5,636.50 |
Torrent Pharmaceuticals Ltd | 4,763.00 | 8.03% | 161,201.56 | 5,085.80 | 3,466.00 |
Cipla Ltd | 1,418.70 | 5.71% | 114,609.01 | 1,673.00 | 1,165.70 |
Zydus Lifesciences Ltd | 1,143.70 | 5.69% | 114,084.51 | 1,181.50 | 835.50 |
Lupin Ltd | 2,443.20 | 5.57% | 111,711.05 | 2,529.50 | 1,836.80 |
Mankind Pharma Ltd | 2,484.20 | 5.11% | 102,596.46 | 2,694.90 | 1,909.70 |
Dr Reddys Laboratories Ltd | 1,211.20 | 5.04% | 101,095.93 | 1,414.90 | 1,148.40 |
Aurobindo Pharma Ltd | 1,533.40 | 4.44% | 89,060.12 | 1,636.80 | 1,016.10 |
Laurus Labs Ltd | 1,529.80 | 4.12% | 82,647.38 | 1,579.10 | 810.05 |
Biocon Ltd | 437.20 | 3.55% | 71,250.23 | 447.15 | 331.00 |
Alkem Laboratories Ltd | 5,563.00 | 3.31% | 66,514.01 | 5,933.50 | 4,738.50 |
Glenmark Pharmaceuticals Ltd | 2,235.50 | 3.14% | 63,085.99 | 2,474.00 | 1,792.60 |
Abbott India Ltd | 28,055.00 | 2.97% | 59,616.88 | 35,310.00 | 25,150.00 |
Ipca Laboratories Ltd | 1,900.60 | 2.40% | 48,219.02 | 1,944.90 | 1,251.60 |
Nifty Pharma Price History
Last Updated: 17 Jul 2026, 12:00 am
| Date | Open (Rs) | High | Low | Close (Rs) |
|---|---|---|---|---|
| 17 Jul 2026 | 25,978.7 | 25,991.25 | 25,549.25 | 25,645 |
| 16 Jul 2026 | 26,060.9 | 26,135.75 | 25,936.35 | 26,008.05 |
| 15 Jul 2026 | 26,027.75 | 26,103.3 | 25,950.1 | 26,003.6 |
| 14 Jul 2026 | 25,640.5 | 26,000.05 | 25,637.6 | 25,907.1 |
| 13 Jul 2026 | 25,613.8 | 25,737.65 | 25,468.85 | 25,643.35 |
| 10 Jul 2026 | 25,681.7 | 25,779.4 | 25,444.2 | 25,674.1 |
| 09 Jul 2026 | 25,422.4 | 25,935.65 | 25,382.55 | 25,656.25 |
| 08 Jul 2026 | 25,669.7 | 25,989.15 | 25,308.95 | 25,429.8 |
| 07 Jul 2026 | 25,874.4 | 26,022.75 | 25,645.9 | 25,677.7 |
| 06 Jul 2026 | 25,805.85 | 25,902.15 | 25,695.85 | 25,866.25 |
| 03 Jul 2026 | 25,402.6 | 25,861.5 | 25,399.9 | 25,745.15 |
| 02 Jul 2026 | 25,301.8 | 25,364.75 | 25,160.3 | 25,308.9 |
| 01 Jul 2026 | 25,416.9 | 25,591.3 | 25,133.25 | 25,182.7 |
| 30 Jun 2026 | 25,274.75 | 25,476.55 | 25,173.05 | 25,326.4 |
| 29 Jun 2026 | 25,098.9 | 25,463.7 | 24,978.05 | 25,227.9 |
About Nifty Pharma
The Nifty Pharma index refers to the index that tracks the performance of top pharmaceutical companies traded on the NSE (National Stock Exchange) in India. It represents companies dealing in the development, manufacturing, and distribution of medicines, healthcare products, and biotech services.
This index usually consists of 20 pharma stocks that span a broad spectrum of the healthcare sector, from generic drug makers and API manufacturers to more research-focused pharmaceutical companies.
When you check Nifty Pharma today, Nifty Pharma live, or Nifty Pharma share price, you're essentially monitoring how India's pharmaceutical sector is performing in response to factors like global demand, regulatory developments, healthcare spending, and innovation trends.
How are the Nifty Pharma Stocks Selected?
The Nifty Pharma index includes top pharmaceutical companies selected based on a defined methodology
Inclusion in Nifty 500
: Companies must be part of the Nifty 500 index. If there are not enough eligible pharma stocks, additional companies may be selected from the top 800 based on liquidity and market capitalization.Sector Classification
: Only companies that are categorized in the pharmaceutical or health care industry are considered.Trading Frequency
: Stocks should have traded on at least 90% of the trading days over the last six months.Listing History
: Companies should have a listing history of at least 1 month as of the review date.Final Selection
: The leading 20 companies are selected based on free-float market capitalization.Weightage Cap
:- A single stock's weight is capped (typically up to 33%)
- The combined weight of top constituents is controlled to maintain diversification
This method ensures that the index includes not only large and stable pharmaceutical companies but also emerging companies in the industry
How is the Nifty Pharma Index Calculated?
The Nifty Pharma index follows the free-float market capitalization method, which only takes into account publicly available shares.
Step 1: Free-Float Market Capitalization
Only shares available for public trading are considered. Promoter holdings and locked-in shares are excluded.Step 2: Assigning Weights
The weightage of each stock is directly proportional to its free-float market capitalization. More influential are the bigger companies.Step 3: Index Aggregation
The weighted market capitalization of all 20 stocks is combined to get the index value.Step 4: Real-Time Tracking
The index is calculated live during market hours, so investors can follow Nifty Pharma's live movements.Step 5: Periodic Rebalancing
The index is reviewed twice a year to show changes in market dynamics, stock performance and sector representation.
Benefits of Investing in Nifty Pharma Stocks
The Nifty Pharma index offers multiple insights and advantages for investors:
- Sector-Focused Exposure: Provides targeted exposure to India's pharmaceutical and healthcare sector.
- Defensive Investment Option: Pharma stocks tend to perform well in an economic downturn due to the consistent demand for healthcare services.
- Global Growth Potential: Many Indian pharma companies have strong exports, making the index sensitive to global healthcare trends.
- Diversification Within Healthcare: Covers companies across generics, APIs, formulations, and research-driven pharma.
- Innovation-Driven Sector: Tracks companies investing in R&D, biosimilars, and specialty drugs.
- Real-Time Monitoring: Investors can track Nifty Pharma today to stay updated on sector performance.
How to Invest in Nifty Pharma with Anand Rathi?
Investing in the Nifty Pharma index is simple with the TradeMobi platform by Anand Rathi:
Step 1: Open or Login to Your Account
Start by logging in or opening a trading account and demat account.Step 2: Search for Investment Options
Search for index funds or ETFs available on the Nifty Pharma index.Step 3: Select Your Investment
Select your investment option according to your investment goals, risk tolerance, and investment horizon.Step 4: Invest Seamlessly
Place your order through the app and complete your investment.Step 5: Track Performance
Get access to Nifty Pharma Index live updates and tracking of your portfolio directly on the app.Step 6: Stay Informed
Keep track of pharma sector news, global developments, and regulatory updates.
History of Nifty Pharma
The Nifty Pharma index was introduced with the purpose of creating a benchmark for India's booming pharmaceutical market. The index has developed with the growth of the pharmaceutical market over the years.
India's pharma sector gained global recognition for its generic drug manufacturing capabilities and cost-efficient production. As Indian companies expanded into regulated markets like the US and Europe, the index began reflecting these global growth trends.
The index has also mirrored key industry phases, such as:
- Growth in exports and API manufacturing
- Increased focus on R&D and specialty drugs
- Regulatory shifts from global health authorities
- Rising demand during global health events
Today, the Nifty Pharma index serves as a key benchmark for healthcare investments and is widely used by fund houses for ETFs, index funds, and portfolio benchmarking.
Explore Popular NSE/BSE Indices
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- Nifty Pharma belongs to India. It depicts how the constituent stocks within the index are performing for a particular period as listed on the NSE.
- The current value of Nifty Pharma is 25,645.00, reflecting the combined price movements of all the constituent stocks present in the index.
- Nifty Pharma recorded a high of 26,135.75 and a low of 21,149.90 over the last 52 weeks, indicating the index's price range during the past year.
- Nifty Pharma performance means how the index has changed over different time periods. It includes short-term, medium-term, and long-term returns based on changes in the index value.
- Nifty Pharma has provided returns of -0.11% over one week, 6.21% over one month, and 13.07% over one year. Long-term returns are 22.20% over three years and 11.82% over five years.
- Nifty Pharma includes 20 carefully selected companies based on pre-defined criteria. Stocks of each constituent company contribute to the index value based on their assigned weightage.
- The present real-time data for Nifty Pharma is sourced from the official stock exchange feeds provided by NSE for accuracy and transparency purposes.
- You cannot directly invest in Nifty Pharma, but you can invest via instruments like index mutual funds, ETFs, and derivatives that track the performance of this index.
- You can track live prices and performance metrics of Nifty Pharma on official stock exchange websites or trusted financial platforms.
